Latest Chronic obstructive pulmonary disease Stories
KONTICH, Belgium, May 9, 2014 /PRNewswire/ -- FLUIDDA's breakthrough imaging technology was used to assess the mode of action of Roflumilast, a novel drug to treat patients
New low-energy sensor eliminates charging, while enhanced analytics identify worsening patients MADISON, Wis., May 6, 2014 /PRNewswire/ -- World Asthma Day --
CHICAGO, May 5, 2014 /PRNewswire/ -- More than two-thirds (69 percent) of U.S.
With allergy season in full swing, medical professionals are hearing more complaints about congestion and trouble breathing.
FORT LEE, N.J., May 1, 2014 /PRNewswire/ -- CareOne, a premier network of senior care centers throughout New Jersey, is at the forefront of a new delivery-of-care system enabling the highest
JACKSON, Miss., May 1, 2014 /PRNewswire-USNewswire/ -- Due to the controversial bidding program operated by the Centers for Medicare & Medicaid Services (CMS), a Mississippi senior citizen
LONDON, April 30, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse(TM) Ellipta(®) (umeclidinium)
- First results of the pivotal Phase 3 INPULSIS(TM) trials investigating the efficacy and safety of nintedanib, an investigational compound, in the treatment of idiopathic pulmonary fibrosis (IPF)
RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., April 28, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc.
Lung Institute Provides Lung Disease Sufferers Advice to Avoid a Flare-Up During Allergy Season (PRWEB) April 24, 2014 To the majority of the population,
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.